Sepio Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $512K | Sell |
18,223
-3,415
| -16% | -$90.9K | 0.03% | 258 |
|
|
2025
Q4 | $539K | Buy |
21,638
+1,465
| +7% | +$36.9K | 0.03% | 236 |
|
|
2025
Q3 | $514K | Buy |
20,173
+812
| +4% | +$20K | 0.03% | 213 |
|
|
2025
Q2 | $469K | Sell |
19,361
-1,151
| -6% | -$26.8K | 0.03% | 216 |
|
|
2025
Q1 | $520K | Sell |
20,512
-26
| -0.1% | -$680 | 0.04% | 218 |
|
|
2024
Q4 | $545K | Sell |
20,538
-130
| -0.6% | -$3.53K | 0.04% | 215 |
|
|
2024
Q3 | $598K | Sell |
20,668
-230
| -1% | -$6.71K | 0.05% | 206 |
|
|
2024
Q2 | $585K | Sell |
20,898
-7
| -0% | -$193 | 0.05% | 200 |
|
|
2024
Q1 | $580K | Buy |
20,905
+4,016
| +24% | +$111K | 0.05% | 204 |
|
|
2023
Q4 | $486K | Sell |
16,889
-70,723
| -81% | -$2.14M | 0.04% | 218 |
|
|
2023
Q3 | $2.91M | Sell |
87,612
-91,764
| -51% | -$3.25M | 0.25% | 85 |
|
|
2023
Q2 | $6.6M | Buy |
179,376
+1,455
| +0.8% | +$56.6K | 0.54% | 41 |
|
|
2023
Q1 | $7.26M | Buy |
177,921
+6,289
| +4% | +$272K | 0.67% | 37 |
|
|
2022
Q4 | $8.79M | Buy |
171,632
+43,472
| +34% | +$2.08M | 0.76% | 23 |
|
|
2022
Q3 | $5.61M | Sell |
128,160
-3,161
| -2% | -$154K | 0.56% | 44 |
|
|
2022
Q2 | $6.88M | Sell |
131,321
-2,558
| -2% | -$130K | 0.69% | 28 |
|
|
2022
Q1 | $6.93M | Buy |
133,879
+1,410
| +1% | +$73.2K | 0.61% | 36 |
|
|
2021
Q4 | $7.82M | Buy |
132,469
+3,888
| +3% | +$193K | 0.58% | 36 |
|
|
2021
Q3 | $5.53M | Buy |
128,581
+6,142
| +5% | +$272K | 0.46% | 48 |
|
|
2021
Q2 | $4.79M | Sell |
122,439
-15,335
| -11% | -$596K | 0.4% | 62 |
|
|
2021
Q1 | $4.99M | Sell |
137,774
-22,195
| -14% | -$788K | 0.46% | 55 |
|
|
2020
Q4 | $5.89M | Sell |
159,969
-17,713
| -10% | -$650K | 0.51% | 52 |
|
|
2020
Q3 | $6.19M | Sell |
177,682
-4,694
| -3% | -$165K | 0.67% | 42 |
|
|
2020
Q2 | $5.66M | Buy |
182,376
+1,514
| +0.8% | +$51.4K | 0.66% | 45 |
|
|
2020
Q1 | $5.61M | Buy |
180,862
+3,112
| +2% | +$106K | 0.74% | 38 |
|
|
2019
Q4 | $6.61M | Sell |
177,750
-192
| -0.1% | -$6.84K | 0.63% | 46 |
|
|
2019
Q3 | $6.07M | Buy |
177,942
+54,696
| +44% | +$1.99M | 0.63% | 44 |
|
|
2019
Q2 | $5.07M | Buy |
123,246
+14,371
| +13% | +$571K | 0.68% | 41 |
|
|
2019
Q1 | $4.39M | Sell |
108,875
-26,198
| -19% | -$1.05M | 0.59% | 43 |
|
|
2018
Q4 | $5.59M | Buy |
+135,073
| New | +$5.61M | 0.41% | 44 |
|
Other funds holding PFE
VCM
VPM
Sepio Capital's PFE Position: Q1 2026 in Review
Sepio Capital reduced its Pfizer (PFE) stake by 16% in Q1 2026, selling an estimated $90.9K and leaving 18,223 shares worth $512K. The position accounts for 0.03% of the portfolio, ranked #258.
Sepio Capital first reported a position in PFE in Q4 2018 and has held it in 30 quarters since. The position peaked at $8.79M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Sepio Capital held 18,223 shares of Pfizer worth $512K as of Q1 2026.
- Sepio Capital sold 3,415 Pfizer shares in Q1 2026, an estimated $90.9K.
- Pfizer made up 0.03% of Sepio Capital's portfolio in Q1 2026, its #258 holding.
- Sepio Capital first reported a position in Pfizer in Q4 2018 and has held it in 30 quarters since.
- Sepio Capital's Pfizer position peaked at $8.79M in Q4 2022.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Sepio Capital's 13F filing for Q1 2026, filed 13 May 2026.